$ALGS

$4.65 -$0.13 (2.72%) Close

$ALGS Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 10.4M shares outstanding

Who owns ALGS?

By type of holder

Institutions 22.0% Everyone else 78.0%

No insider has reported a holding in the last two years, so insiders are counted in "Everyone else".

Concentration Top 10 holders own 21.8%

Deep Track Capital, LP 4.3% · Alyeska Investment Group, L.P. 4.0%

Institutional ownership

22.0%

-4.6 pts vs last qtr

Institutional holders

-3 vs last qtr

Net shares bought

−482.5K

by institutions in Q2 2026

New / sold out

5 / 8

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

D. E. Shaw & Co., Inc. +55.5K
Jane Street Group, LLC NEW +32.4K

Biggest sellers in Q2 2026

Bank Of America Corp /de/ SOLD OUT −229.8K
SummitTX Capital, L.P. SOLD OUT −148.8K

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Aligos Therapeutics, Inc. in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2022–FY2025

+478.8%

+79.55% a year

Each share's claim on the business

−82.7%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

— vs $40.8M

over 4 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

Institutional shares by how long they've been held

5+ years0% 3–5 years0% 1–3 years82% Under 1 year18%

Quarterly turnover

14.7%

of institutional shares changed hands

Top 10 managers, median time held

1.8 years

Super Investors

Investment managers reporting ALGS on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
DT Deep Track Capital, LP	444.1K	4.26%	Unchanged	2024	0.0%
Shares held by quarter Peak holding444.1K (Q1'25) Change over 8 quarters+200.0K Share of the company4.260% Deep Track Capital, LP's full portfolio →
AI Alyeska Investment Group, L.P.	412.0K	3.95%	Unchanged	2025	0.0%
Shares held by quarter Peak holding412.0K (Q1'25) Change over 8 quarters+412.0K Share of the company3.950% Alyeska Investment Group, L.P.'s full portfolio →

Deep Track Capital, LP

444.1K

% of company

4.26%

Change vs last qtr

Unchanged

Held since

2024

Alyeska Investment Group, L.P.

412.0K

% of company

3.95%

Change vs last qtr

Unchanged

Held since

2025

28 more super investors behind a free account

See every manager holding Aligos Therapeutics, Inc., how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting ALGS on Form N-PORT; together they hold 2.5% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
VT Vanguard Total Stock Market Index Fund Vanguard Index Funds	$743K	128.8K	1.23%	0.00%	June 30, 2026
VE Vanguard Extended Market Index Fund Vanguard Index Funds	$270K	46.8K	0.45%	0.00%	June 30, 2026

Vanguard Total Stock Market Index Fund

Vanguard Index Funds

Position value

$743K

% of company

1.23%

% of the fund

0.00%

As of

June 30, 2026

Vanguard Extended Market Index Fund

Vanguard Index Funds

Position value

$270K

% of company

0.45%

% of the fund

0.00%

As of

June 30, 2026

19 more funds behind a free account

See every fund holding Aligos Therapeutics, Inc. and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
LM Lawrence M. Blatt 5%+ holder 13D · 5.6%	316.2K	3.03%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company3.030% Disclosed stake13D · 5.6% View the 13D/G filing →

Lawrence M. Blatt

5%+ holder13D · 5.6%

316.2K

% of company

3.03%

Change vs last qtr

—

Held since

—

Comments